Merck KGaA
Editor: Lin Jiayi | Updated: 2026-10-28
On June1, 2026, Germany’s Merck Group, with a history spanning 358 years, completed construction of its Greater Bay Area innovation and collaboration center at Nanshan iPark in Shenzhen’s Nanshan District.
Focusing on life sciences and healthcare, the center brings together global innovation resources to advance research and development in innovative medicines and biotechnology. The global science and technology company, which entered China 93 years ago, has located its core Greater Bay Area innovation platform in Shenzhen.
Source: The Paper via Shenzhen News 3 September 2026 (《深圳:奇迹之城何以成为世界之窗》).
Under the plans, the center is primarily intended to serve as an innovation and research platform for the group, focusing on life sciences and healthcare. It will bring together global innovation resources to advance research and development in innovative medicines and biotechnology. Its functions will include incubating high-quality projects from global biopharmaceutical companies, developing talent, and conducting research and development in innovative medicines and medical devices.
The center will also serve as a Merck accelerator. Through measures including the establishment of advanced laboratories and industry funds, it will provide comprehensive technical and financial support to promising startups worldwide in life sciences, healthcare, electronics and other emerging technology fields.
Source: CRI Online 2 June 2026 text supplied by the Nanshan District Science and Technology Innovation Bureau (《德国默克集团大湾区创新与合作中心在深圳南山落成》).

The Merck logo at the company’s Greater Bay Area innovation and collaboration center in Shenzhen’s Nanshan District. Lin Jianping

Merck China President Rogier Janssens(C) tours laboratory facilities at the newly inaugurated GBA Innovation and Collaboration Center in Nanshan. Lin Jianping